BiotechTube
Home/Clene/Michael Hotchkin
MH

Michael Hotchkin

Chief Development Officer

Clene

Therapeutic Areas

Neurodegenerative DiseasesMultiple SclerosisAmyotrophic Lateral SclerosisParkinson's Disease

Clene Pipeline

DrugIndicationPhase
CNM-Au8Amyotrophic Lateral Sclerosis (ALS)Phase 2/3

Leadership Team at Clene

RE
Rob Etherington
President & CEO
MM
Mark Mortenson
Chief Science Officer
MB
Morgan Brown
Chief Financial Officer
BG
Benjamin Greenberg
Head of Medical
JZ
Joanne Zhongyan Zhang
Director of Micro and Biology
DK
D. Kyle Pierce
Vice President, Research & Development
AR
Austin Rynders
Vice President, Clinical Operations
AD
Adam Dorfman
Vice President, Quality & Technical Operations
JM
Jerry Miraglia
General Counsel and Corporate Secretary
MA
Mary Anne McNeil
Head of Human Resources
View full Clene profile